JAK2 and thyroid cancer: In addition, AG490, a JAK2 antagonist, enhanced the anti-migratory and anti-invasive effects of oridonin on thyroid cancer cells, which were confirmed by western blotting, Transwell migration assay and Matrigel invasion assay.